Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Akoya Biosciences (AKYA)
NASDAQ:AKYA
Akoya Biosciences (AKYA) Stock Price & Analysis
113 Followers
AKYA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.04 - $8.80
Previous Close$3.98
Volume310.09K
Average Volume (3M)185.40K
Market Cap
$197.05M
Enterprise Value$199.64M
Total Cash (Recent Filing)$83.13M
Total Debt (Recent Filing)$85.71M
Price to Earnings (P/E)-2.7
Beta1.98
Next Earnings
May 14, 2024EPS Estimate
-$0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.49
Shares Outstanding49,140,731
10 Day Avg. Volume150,138
30 Day Avg. Volume185,403
Standard Deviation0.16
R-Squared0.22
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)11.22
Price to Sales (P/S)2.04
Price to Cash Flow (P/CF)-9.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.07
Enterprise Value/Gross Profit2.43
Enterprise Value/Ebitda-4.70
Forecast
1Y Price Target
$8.90Price Target Upside123.62% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Akoya Biosciences News
Ownership Overview
39.31% Insiders
5.45% Mutual Funds
23.17% Other Institutional Investors
32.07% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AKYA FAQ
What was Akoya Biosciences’s price range in the past 12 months?
Akoya Biosciences lowest stock price was $3.04 and its highest was $8.80 in the past 12 months.
What is Akoya Biosciences’s market cap?
Currently, no data Available
When is Akoya Biosciences’s upcoming earnings report date?
Akoya Biosciences’s upcoming earnings report date is May 14, 2024 which is in 24 days.
How were Akoya Biosciences’s earnings last quarter?
Akoya Biosciences released its earnings results on Mar 04, 2024. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.269 by $0.049.
Is Akoya Biosciences overvalued?
According to Wall Street analysts Akoya Biosciences’s price is currently Undervalued.
Does Akoya Biosciences pay dividends?
Akoya Biosciences does not currently pay dividends.
What is Akoya Biosciences’s EPS estimate?
Akoya Biosciences’s EPS estimate is -$0.29.
How many shares outstanding does Akoya Biosciences have?
Akoya Biosciences has 49,140,730 shares outstanding.
What happened to Akoya Biosciences’s price movement after its last earnings report?
Akoya Biosciences reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.269. Following the earnings report the stock price went down -14.716%.
Which hedge fund is a major shareholder of Akoya Biosciences?
Among the largest hedge funds holding Akoya Biosciences’s share is Fisher Asset Management LLC. It holds Akoya Biosciences’s shares valued at N/A.
---
Akoya Biosciences Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.90 (123.62% Upside)
$8.90 (123.62% Upside)
Blogger Sentiment
Bullish
AKYA Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.7M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 12.3%
Last 30 Days ▼ 12.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-43.46%
12-Months-Change
Fundamentals
Return on Equity
-112.72%
Trailing 12-Months
Asset Growth
2.46%
Trailing 12-Months
Company Description
Akoya Biosciences
Akoya Biosciences Inc is an an innovative life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery and clinical research. It offers the most comprehensive, end-to-end solutions for high-parameter tissue analysis from discovery through clinical and translational research, enabling the development of more precise therapies for immuno-oncology and other drug development applications.
---
AKYA Earnings Call
Q4 2024
0:00 / 0:00
---
AKYA Stock 12 Months Forecast
Average Price Target
$8.90
▲(123.62% Upside)
Technical Analysis
Best Analysts Covering AKYA
1 Year
1 Year Success Rate
2/9 ratings generated profit
1 Year Average Return
-23.83%
reiterated a buy rating 6 months ago
Copying Tejas Savant's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -23.83% per trade.
---